| Page 47 | Cafepharma

You are here

Primary tabs

Innovate to Study Larazotide's Effect on Microbiome of Children with EED

Post date: July 31, 2018 - 10:02am

Pfizer Receives European Approval for Herceptin Biosimilar, Trazimera

Post date: July 31, 2018 - 9:44am

Opdivo Approved in Europe for Additional Use in Melanoma Patients

Post date: July 31, 2018 - 9:29am

Researchers Discovery Way to Regenerate Neurons Damaged by Glaucoma

Post date: July 31, 2018 - 9:17am

ContraFect Corporation Prices $10 Million Public Offering of Common Stock to Develop Novel Infectious Disease Treatments

Post date: July 30, 2018 - 9:45am

HitGen and Merck Expand Collaboration to Build Novel DNA-Ecoded Libraries for Drug Discovery

Post date: July 30, 2018 - 9:28am

BeiGene Proposes $800+ Million Offering

Post date: July 27, 2018 - 10:37am

Alnylam Receives Positive CHMP Opinion for Hereditary Amyloidosis Treatment

Post date: July 27, 2018 - 10:01am

Keytruda Becomes the First Anti-PD-1 Therapy Approved in China for Advanced Melanoma

Post date: July 26, 2018 - 9:47am

Omeros Prevails in Patent Dispute With Sandoz

Post date: July 26, 2018 - 9:12am

Pages